Viewing StudyNCT00249171



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00249171
Status: COMPLETED
Last Update Posted: 2011-01-14
First Post: 2005-11-04

Brief Title: A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients
Sponsor: Janssen Pharmaceutica NV Belgium
Organization: Janssen Pharmaceutica NV Belgium

Organization Data

Organization: Janssen Pharmaceutica NV Belgium
Class: INDUSTRY
Study ID: CR003175
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Janssen Pharmaceutica NV Belgium
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators